Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Posts 147 Percent Revenue Growth for Q3

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Genetics today reported that its third-quarter revenues increased 147 percent year over year, driven by sales of its ResponseDX genetic tests.

The Los Angeles-based firm reported total revenues of $5.6 million for the three-month period ended Sept. 30, compared to $2.3 million for Q3 2009. Sales for the firm's ResponseDX genetic tests rose 226 percent year over year to $3 million from $900,000, the firm said. It added that revenues derived from pharmaceutical clients were $2.6 million, up 92 percent from $1.4 million in Q3 2009.

Response Genetics posted a net loss of $1.1 million, or $.06 per share, down sharply from a net loss of $2 million, or $.14 per share, for the third quarter of 2009.

Its R&D spending dropped to $319,271 from $726,696, while its SG&A expenses jumped to $3.6 million from $2.3 million.

Response Genetics had $5.4 million in cash and cash equivalents as of the end of the quarter.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.